Science for Life.
ProPhase Labs develops and markets clinically proven remedies including the highly effective Cold-EEZE® and Kids-EEZE® product lines. Our ongoing objective is to deliver long-term value by providing exceptional new products that address the health care and quality of life concerns of the broadest market segments.
March 25, 2015 - ProPhase Labs Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2014
November 17, 2014 - ProPhase Labs Reports Financial Results for the Three and Nine Months Ended September 30, 2014
September 10, 2014 - ProPhase Expects to Report a $3.6 Million Impairment Charge Relating to its Phusion Joint Venture
The Cold-EEZE® family of lozenges are clinically proven to reduce the duration of the common cold.